(SREN) Swiss Re - Ratings and Ratios
Reinsurance, Insurance, Risk Management
SREN EPS (Earnings per Share)
SREN Revenue
Description: SREN Swiss Re
Swiss Re AG is a global reinsurer that provides a wide range of risk transfer and insurance-related services to various clients, including insurance companies, corporations, and individuals. With a rich history dating back to 1863, the company has established itself as a leading player in the reinsurance industry, operating through three main segments: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. Its diversified business model allows it to capitalize on opportunities across different markets and geographies.
The companys Property & Casualty Reinsurance segment is a significant contributor to its top-line, offering a broad range of reinsurance solutions, including property, casualty, and specialty lines. Meanwhile, the Life & Health Reinsurance segment provides reinsurance coverage for life and health insurance products, helping insurers manage their risk exposure. The Corporate Solutions segment, on the other hand, offers customized insurance solutions to mid-sized and large corporations, as well as public sector entities.
From a technical analysis perspective, Swiss Re AGs stock price has been trending within a relatively narrow range, with the 20-day SMA at 148.20 CHF and the 50-day SMA at 143.98 CHF. The stock is currently trading at 146.05 CHF, slightly below its 20-day SMA. The ATR indicator suggests a moderate level of volatility, with an average true range of 2.66 CHF (1.82%). Given the current technical setup, its likely that the stock will continue to consolidate within a tight range, potentially breaking out above 150 CHF or falling below 140 CHF in the near term.
Fundamentally, Swiss Re AGs market capitalization stands at approximately 42.8 billion CHF, with a P/E ratio of 16.41 and a forward P/E of 12.39. The companys return on equity (RoE) is a respectable 19.02%, indicating a relatively strong ability to generate profits from shareholder equity. Considering the companys solid fundamental profile and the current technical setup, a potential forecast could be that the stock price will appreciate to around 155-160 CHF in the next 6-12 months, driven by a combination of improving profitability and a rebound in the stock price.
Based on the available data, a possible trading strategy could involve buying the stock on dips towards 140-142 CHF, with a target price of 155-160 CHF and a stop-loss level around 135 CHF. However, its essential to closely monitor the companys future earnings reports, industry trends, and macroeconomic developments to adjust the forecast and trading strategy accordingly.
Additional Sources for SREN Stock
SREN Stock Overview
Market Cap in USD | 50,929m |
Sector | Financial Services |
Industry | Insurance - Reinsurance |
GiC Sub-Industry | Reinsurance |
IPO / Inception |
SREN Stock Ratings
Growth Rating | 91.2 |
Fundamental | 51.6 |
Dividend Rating | 61.6 |
Rel. Strength | 6.06 |
Analysts | - |
Fair Price Momentum | 154.82 CHF |
Fair Price DCF | 223.00 CHF |
SREN Dividends
Dividend Yield 12m | 4.54% |
Yield on Cost 5y | 10.79% |
Annual Growth 5y | 1.05% |
Payout Consistency | 88.3% |
Payout Ratio | 52.6% |
SREN Growth Ratios
Growth Correlation 3m | -36.4% |
Growth Correlation 12m | 91.4% |
Growth Correlation 5y | 93.4% |
CAGR 5y | 20.68% |
CAGR/Max DD 5y | 0.79 |
Sharpe Ratio 12m | 0.58 |
Alpha | 22.62 |
Beta | 0.647 |
Volatility | 18.81% |
Current Volume | 556.2k |
Average Volume 20d | 521.1k |
Stop Loss | 135.9 (-3.5%) |
As of July 13, 2025, the stock is trading at CHF 140.80 with a total of 556,158 shares traded.
Over the past week, the price has changed by +0.54%, over one month by -0.88%, over three months by +6.50% and over the past year by +32.93%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Swiss Re (SW:SREN) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 51.64 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SREN is around 154.82 CHF . This means that SREN is currently overvalued and has a potential downside of 9.96%.
Swiss Re has no consensus analysts rating.
According to our own proprietary Forecast Model, SREN Swiss Re will be worth about 172.3 in July 2026. The stock is currently trading at 140.80. This means that the stock has a potential upside of +22.39%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 138.3 | -1.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 172.3 | 22.4% |